CIK: 1631667 - Address: C/O Biora Therapeutics, Inc., 4330 La Jolla Village Drive, Suite 300, San Diego, CA 92122
20 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/29/19 16:21
1/25/19
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCM.dm393.220120D
1/29/19 16:21
1/25/19
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCS.dm-1179.750-12-1000D
1/23/19 16:12
1/18/19
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCM.d63.22020D
1/23/19 16:12
1/18/19
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCS.d-199.400-2-1000D
1/18/19 16:03
1/16/19
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCM.d103.22030D
1/18/19 16:03
1/16/19
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCS.d-289.270-3-1000D
1/16/19 16:24
1/14/19
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCM.d33.22010D
1/16/19 16:24
1/14/19
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCS.d-99.200-1-1000D
12/12/18 16:13
12/10/18
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCM.d133.22040D
12/12/18 16:13
12/10/18
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCS.d-369.060-4-1000D
11/21/18 16:51
11/19/18
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCM.dm303.22092D
11/21/18 16:51
11/19/18
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCS.dm-1328.550-15-862D
11/9/18 16:11
11/7/18
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCM.dm183.22061849D
11/9/18 16:11
11/7/18
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCS.dm-458.140-6-399D
11/7/18 16:05
11/5/18
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCM.d03.220019D
11/7/18 16:05
11/5/18
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCS.d-18.0000-19D
11/6/18 16:07
11/2/18
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCM.d33.2201139D
11/6/18 16:07
11/2/18
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCS.d-88.000-1-109D
11/5/18 13:17
11/1/18
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCS-127.510-2-159D
10/23/18 13:31
10/19/18
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagPowell LynneNCOSVP - CCS-17.5000-110D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact